Source: ERS Lung Science Conference 2017
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Richard Marshall (Stevenage, United Kingdom). Dissecting chronic lung disease. ERS Lung Science Conference 2017

Member's Comments

No comment yet.

Related content which might interest you: Prediction of chronic lung disease Source: Eur Respir J 2003; 22: Suppl. 45, 139s Year: 2003 Senotherapies for chronic lung disease Source: ERS Lung Science Conference 2020 Year: 2020 Implication of microRNA-148b in chronic obstructive lung disease of betaENaC-overexpressing mice Source: Annual Congress 2013 –New strategies in epigenomic research to study lung diseases (DNA rearrangements, RNA, methylation, proteosome) Year: 2013 Systemic inflammation: a link between chronic obstructive pulmonary disease and lung cancer? Source: Annual Congress 2009 - Biological and clinical markers in lung cancer Year: 2009 The link between inflammation and lung cancer: lessons from chronic obstructive pulmonary disease Source: International Congress 2018 – Scientific Year in Review Year: 2018 Impact of COVID-19 on patients with chronic lung disease Source: Virtual Congress 2021 – COVID - 19 epidemiology Year: 2021 Peripheral lung remodelling in asthma and chronic obstructive pulmonary disease Source: Eur Respir J 2004; 24: 893-894 Year: 2004 Siphonage lung disease Source: Virtual Congress 2020 – Respiratory critical care Year: 2020 Characterisation of severity in paediatric chronic suppurative lung disease Source: Virtual Congress 2021 – Paediatric respiratory infections: chronic infection, vaccination and lung function Year: 2021 Tele-rehabilitation in chronic lung diseases Source: ERS Course 2017 Year: 2017 Variability in expression of aquoporine 1 in chronic obstructive pulmonary disease and interstitial lung disease patients Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease? Year: 2009 Inflammatory markers in patients with acute exacerbation of chronic obstructive pulmonary disease and role of bacterial infection Source: Annual Congress 2010 - Colonisation and infection in COPD Year: 2010 Analysis of parameters of lung function in patients with severe chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 214s Year: 2001 Mild parenchymal lung disease is still lung disease Source: Eur Respir J, 56 (5) 2003542; 10.1183/13993003.03542-2020 Year: 2020 Mild parenchymal lung disease is still lung disease Source: Eur Respir J, 56 (5) 2003727; 10.1183/13993003.03727-2020 Year: 2020 Possible mechanisms underlying the development of cachexia in COPD Source: Eur Respir J 2008; 31: 492-501 Year: 2008 Dynamics etiologic spectrum of infectious exacerbation of chronic obstructive pulmonary disease Source: Annual Congress 2010 - Colonisation and infection in COPD Year: 2010